Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking

BACKGROUND: Estimates of the risk of developing Crohn's disease (CD) can be made using DNA testing for mutations in the NOD2 (CARD15) gene, family history, and smoking status. Smoking doubles the risk of CD, a risk that is reduced by stopping. CD therefore serves as a timely and novel paradigm...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Whitwell, Sophia CL, Mathew, Christopher G, Lewis, Cathryn M, Forbes, Alastair, Watts, Sally, Sanderson, Jeremy, Hollands, Gareth J, Prevost, A Toby, Armstrong, David, Kinmonth, Ann Louise, Sutton, Stephen, Marteau, Theresa M
التنسيق: Artigo
اللغة:Inglês
منشور في: BioMed Central 2011
الموضوعات:
Study Protocol
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3036624/
https://ncbi.nlm.nih.gov/pubmed/21247480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2458-11-44
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة